Karuna Therapeutics Inc. (KRTX) Tops Q1 EPS by 7c

Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q1 EPS of $2.80, $0.07 better than the analyst estimate of $2.73. Revenue for the quarter came in at $650 thousand versus the consensus estimate of $76.92 thousand.

For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79